ExodusPoint Capital Management, LP

Position in NVO — Novo Nordisk A S

CIK 1736225 NEW YORK, NY

Position in NVO

as of Jun 30, 2026 · filed Aug 14, 2026 Compact

Position Value

$8,181,056

-$5,773,903 QoQ

Shares Held

170,652

-37.8% QoQ

Ownership

0.004%

of shares outstanding

% of Portfolio

0.08%

of 13F equity value

Holder Rank

#164

of 1,348 holders

Holding Since

Mar 2020

14 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Jun 30, 2026

ExodusPoint Capital Management, LP holds $41,945,321 across 5 Drug Manufacturers - General names. NVO ranks #3 (19.5% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	LLY	ELI LILLY & Co	14,472	$17,358,152
2	BMY	Bristol Myers Squibb Co	253,748	$14,620,959
3	NVO	Novo Nordisk A S This page	170,652	$8,181,056
4	OGN	Organon & Co.	86,030	$1,164,846
5	BIIB	Biogen Inc.	2,871	$620,308

14 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$8,181,056	170,652	-37.8%	Shares	Sole	2026-08-14
2025-12-31	$13,954,959	274,272	+136.9%	Shares	Sole	2026-02-17
2024-09-30	$13,786,519	115,785	+7182.1%	Shares	Sole	2024-11-12
2023-06-30	$257,309	1,590	-98.4%	Shares	Sole	2023-08-11
2023-03-31	$15,787,961	99,208	+42.0%	Shares	Sole	2023-05-11
2022-12-31	$9,454,852	69,860	+212.7%	Shares	Sole	2023-02-13
2022-09-30	$2,225,734	22,340	-87.2%	Shares	Other	2022-11-10
2022-06-30	$19,397,288	174,076	+771.3%	Shares	Other	2022-08-22
2022-03-31	$2,218,779	19,980	+136.6%	Shares	Other	2022-05-13
2021-12-31	$945,616	8,443	-55.3%	Shares	Sole	2022-02-11
2021-03-31	$1,273,766	18,893	+90.0%	Shares	Other	2021-05-17
2020-12-31	$694,448	9,942	+43.0%	Shares	Sole	2021-02-16
2020-06-30	$455,282	6,953	+81.4%	Shares	Sole	2020-08-14
2020-03-31	$230,686	3,832	—	Shares	Sole	2020-05-15
No filing history on record for this holder in this stock.